» Articles » PMID: 31884566

Behind the Pathology of Macrophage-associated Demyelination in Inflammatory Neuropathies: Demyelinating Schwann Cells

Overview
Publisher Springer
Specialty Biology
Date 2019 Dec 30
PMID 31884566
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In inflammatory peripheral demyelinating disorders, demyelination represents segmental demyelination in which the myelin sheath of a myelinating Schwann cell (SC) is completely removed by macrophages or a partial myelin degeneration in the paranode occurring due to autoantibodies attacking the node/paranode. For the segmental demyelination from living myelin-forming SCs, macrophages infiltrate within the endoneurium and insinuate between myelin lamellae and the cytoplasm of SCs, and the myelin is then removed via phagocytosis. During the macrophage invasion into the SC cytoplasm from the node of Ranvier and internodal areas, the attacked SCs do not remain quiescent but transdifferentiate into inflammatory demyelinating SCs (iDSCs), which exhibit unique demyelination pathologies, such as myelin uncompaction from Schmidt-Lanterman incisures with myelin lamellae degeneration. The longitudinal extension of this self-myelin clearance process of iDSCs into the nodal region is associated with the degeneration of nodal microvilli and paranodal loops, which provides a potential locus for macrophage infiltration. In addition to the nodal intrusion, macrophages appear to be able to invade fenestrated internodal plasma membrane or the degenerated outer mesaxon of iDSC. These SC demyelination morphologies indicate that the SC reprogramming to iDSCs may be a prerequisite for macrophage-mediated inflammatory demyelination. In contrast, paranodal demyelination caused by autoantibodies to nodal/paranodal antigens does not result in iDSC-dependent macrophage infiltration and subsequent segmental demyelination. In the context of inflammatory demyelination, the novel perspective of iDSCs provides an important viewpoint to understand the pathophysiology of demyelinating peripheral neuropathies and establish diagnostic and therapeutic strategies.

Citing Articles

High Blood Pressure and Impaired Brain Health: Investigating the Neuroprotective Potential of Magnesium.

Alateeq K, Walsh E, Cherbuin N Int J Mol Sci. 2024; 25(22).

PMID: 39595928 PMC: 11594239. DOI: 10.3390/ijms252211859.


Interruptible demyelination in avian riboflavin deficient neuropathy.

Cai Z Cell Biosci. 2024; 14(1):52.

PMID: 38649908 PMC: 11036723. DOI: 10.1186/s13578-024-01233-5.


Adaptive Autonomic and Neuroplastic Control in Diabetic Neuropathy: A Narrative Review.

Marsili F, Potgieter P, Birkill C Curr Diabetes Rev. 2023; 20(8):38-54.

PMID: 38018186 DOI: 10.2174/0115733998253213231031050044.


Role of transforming growth factor-β in peripheral nerve regeneration.

Ding Z, Jiang M, Qian J, Gu D, Bai H, Cai M Neural Regen Res. 2023; 19(2):380-386.

PMID: 37488894 PMC: 10503632. DOI: 10.4103/1673-5374.377588.


Exogenous Antioxidants in Remyelination and Skeletal Muscle Recovery.

Cabezas Perez R, Avila Rodriguez M, Rosero Salazar D Biomedicines. 2022; 10(10).

PMID: 36289819 PMC: 9599955. DOI: 10.3390/biomedicines10102557.


References
1.
Man Ng J, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T . Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012; 79(23):2241-8. PMC: 3542349. DOI: 10.1212/WNL.0b013e31827689ad. View

2.
Brosius Lutz A, Barres B . Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev Cell. 2014; 28(1):7-17. DOI: 10.1016/j.devcel.2013.12.002. View

3.
Fehmi J, Scherer S, Willison H, Rinaldi S . Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry. 2017; 89(1):61-71. DOI: 10.1136/jnnp-2016-315480. View

4.
Devaux J, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M . Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology. 2016; 86(9):800-7. PMC: 4793783. DOI: 10.1212/WNL.0000000000002418. View

5.
Jang S, Shin Y, Park S, Park J, Lee H, Yoo Y . Autophagic myelin destruction by Schwann cells during Wallerian degeneration and segmental demyelination. Glia. 2015; 64(5):730-42. DOI: 10.1002/glia.22957. View